The T2DM patients had higher fasting blood glucose (FBG), HbA1c, insulin, and alanine aminotransferase (ALT) levels, and homeostasis model of insulin resistance (HOMA-IR) values, than the control subjects. The gene discussed is GPT; the disease is type 2 diabetes mellitus.